Results 91 to 100 of about 46,339 (291)

N-terminal-pro-brain natriuretic peptide, but not brain natriuretic peptide, is increased in patients with severe obesity

Brazilian Journal of Medical and Biological Research, 2007
Elevated body mass index (BMI) has been reported as a risk factor for heart failure. Prevention of heart failure through identification and management of risk factors and preclinical phases of the disease is a priority.
F. Fernandes, F.J.A. Ramires, P.C. Buck, I.J. Almeida, R. Rabelo, S.A. Dantas, V.M.C. Salemi, A. Halpern, C. Mady   +8 more
doaj  

N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN DIAGNOSTICS OF NON-COMPACTED MYOCARDIUM IN CHILDREN

Педиатрическая фармакология, 2012
Non-compacted myocardium is a rare congenital cardiomyopathy. Due to the lack of uniform criteria, diagnostics of this condition is complicated presently, which results in over-diagnosing.
E. N. Arkhipova, I. V. Sil’nova, E. N. Basargina, I. V. Dvoryakovskii, A. B. Sugak, N. A. Mayanskii, M. K. Umarova   +6 more
doaj   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction [PDF]

, 2019
Aims: Impaired left ventricular diastolic function leading to elevated left atrial pressures, particularly during exertion, is a key driver of symptoms and outcomes in heart failure with preserved ejection fraction (HFpEF). Insertion of an interatrial
Aytug, H, Bergmann, MW, Doughty, RN, Gustafsson, F, Hasenfuβ, G, Hausleiter, J, Hayward, C, Jondeau, G, Kaye, DM, Kolodziej, A, Lang, I, Malek, F, McKenzie, S, Penicka, M, Petrie, MC, Ponikowski, P, Post, M, Raake, P, REDUCE LAP-HF study investigators,, Rosenberg, M, Spelman, T, Trochu, J-N, Westenfeld, R   +22 more
core   +2 more sources

ST2 and Multimarker Testing in Acute Decompensated Heart Failure [PDF]

, 2015
Most data on heart failure biomarkers have been derived from patient cohorts with chronic disease. However, risk prediction in patients admitted with acute decompensated heart failure (ADHF) remains a challenge.
Antoni, Md, Bayes, Genis, DI SOMMA, Salvatore, Maisel, Alan S., Md,, Md,, Md,, Mebazaa, Alexandre   +7 more
core   +1 more source

Diabetic cardiomyopathy: diagnostic biomarkers

Mìžnarodnij Endokrinologìčnij Žurnal, 2020
The review provides a classification of biomarkers of the cardiovascular system diseases, biological markers that have found application in a cardiological clinic, biomarkers of heart failure, modern recommendations on the use of biomarkers for the ...
V.A. Serhiyenko, A.A. Serhiyenko
doaj   +1 more source

Correlates and short-term prognostic value of plasma n-terminal pro-brain natriuretic peptide levels among heart failure patients: A prospective cohort study [PDF]

, 2021
Mark Mayala, Khuzeima Khanbhai, Ponsian Peter, Pilly Chillo   +3 more
openalex   +1 more source

Reply to: N-terminal pro brain natriuretic peptide in coronary artery disease

Journal of the Saudi Heart Association, 2015
In response to the letter by Professor Sim Sai Tin, we agree that the clinical usefulness of NT-proBNP has been widely discussed. Dr. Sim Sai Tin mentions the report by Ranjith et al. [1] on the usefulness of this biomarker in which the authors suggest that “NT-proBNP should be included in the risk assessment of ACS to provide guidance for further ...
Radwan, Hanan, Selem, Abdelhakem, Ghazal, Kamel   +2 more
openaire   +2 more sources

Biomarker profiles of acute heart failure patients with a mid-range ejection fraction [PDF]

, 2017
OBJECTIVES: In this study, the authors used biomarker profiles to characterize differences between patients with acute heart failure with a midrange ejection fraction (HFmrEF) and compare them with patients with a reduced (heart failure with a ...
Bloomfield, Daniel M, Cleland, John G.F., Cotter, Gad, Davison, Beth, Dittrich, Howard C, Givertz, Michael M, Hillege, Hans L, Khan, Mohsin A F, Mentz, Robert J, Metra, Marco, O'Connor, Christopher M, Ponikowski, Piotr, Teerlink, John R, Tromp, Jasper, van der Meer, Peter, Van Veldhuisen, Dirk J, Voors, Adriaan A.   +16 more
core   +2 more sources

Comprehensive exploration of unexplained dyspnoea in subjects with normal ejection fraction and low natriuretic peptides

ESC Heart Failure, Volume 12, Issue 2, Page 879-887, April 2025.
Abstract Background Unexplained exertional dyspnoea without significant elevation of natriuretic peptides is common. One of the causes might be early heart failure with preserved ejection fraction (HFpEF). Aims This study aimed to characterize patients with exertional dyspnoea and normal/near‐to‐normal N‐terminal pro‐brain natriuretic peptide (NT ...
Emmanuelle Berthelot, Tarek Laouar, Antoine Beurnier, Nataliya Hrynchynshyn, Jean Christophe Eicher, Jean‐Michel Tartière, Patrick Jourdain, Olivier Lairez, Barnabas Gellen   +8 more
wiley   +1 more source